Request Deal Involvement
Shin Nippon Biomedical Laboratories to acquire Satsuma Pharmaceuticals for $220m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Houlihan Lokey
financial advisors
Lazard
legal advisors
Latham & Watkins
pr advisors
LifeSci Partners
legal advisors
Wilson Sonsini Goodrich & Rosati
legal advisors
TMI Associates
or
Principals
target
SATSUMA PHARMACEUTICALS
bidder
SHIN NIPPON BIOMED LAB
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite